NCT06547619View on ClinicalTrials.gov

Role of ET-1, Physical Activity, and Sedentary Behavior in Microvascular Dysfunction Following GDM

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

October 1, 2024

Primary Completion Date

May 31, 2026

Study Completion Date

May 31, 2027

Conditions
Gestational DiabetesEndothelial DysfunctionPhysical Inactivity
Interventions
DRUG

Insulin aspart

insulin aspart is perfused at 5 ascending concentrations (10\^-8M - 10\^-4 M) for 10 minutes each

Trial Locations (1)

52242

RECRUITING

University of Iowa, Iowa City

All Listed Sponsors
lead

Anna Stanhewicz, PhD

OTHER